BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 26
• 27
• 28
• 29
• 30

• Business

  Cell Therapeutics, Inc. Appoints Monique Greer, Senior Vice President, Corporate Communications and Investor Relations

  November 12, 2012

   · 

  2 min read
• Pharm Country

  Enzo Biochem to Present at Lazard Capital Markets 9th Annual Healthcare Conference

  November 12, 2012

   · 

  1 min read
• Drug Development

  Efficacy and Safety Data From Phase 2B Trials of Janssen’s Simeprevir in Hepatitis C Patients With Advanced Fibrosis of the Liver Presented at Annual Meeting of the American Association for Study of Liver Diseases

  November 12, 2012

   · 

  7 min read
• BioCapital

  AstraZeneca PLC Launches New Digital Resources for ARIMIDEX® (anastrozole) Tablets to Help Educate Patients About ARIMIDEX Direct

  November 12, 2012

   · 

  1 min read
• Pharm Country

  Derma Sciences, Inc. to Present at the Lazard Capital Markets 9th Annual Healthcare Conference

  November 12, 2012

   · 

  1 min read
• Biotech Beach

  SetPoint Medical Presents Positive Clinical Results for First Human Study of Implantable Neuromodulation Device for Rheumatoid Arthritis

  November 12, 2012

   · 

  1 min read
• Drug Development

  3-V Biosciences Presents Positive Preclinical Data on HCV Product Candidates Targeting FASN at the American Association for Study of Liver Diseases Annual Meeting 2012

  November 12, 2012

   · 

  3 min read
• Bio NC

  DARA BioSciences, Inc. Will Present at NYSSA Investing in Life Sciences Conference, November 29

  November 12, 2012

   · 

  1 min read
• Genetown

  Infinity Pharmaceuticals Inc. Reports Phase 1 Data for IPI-145 at American College of Rheumatology/ARHP Supporting Development in Inflammatory Conditions

  November 12, 2012

   · 

  1 min read
• Drug Development

  AEterna Zentaris Announces Initiation of Phase 2 Portion of Phase 1/2 Trial with AEZS-108 in Prostate Cancer

  November 12, 2012

   · 

  5 min read